Fertility Clinical Trial
Official title:
Effect of Timing of Oocyte Denudation Before ICSI and Its Results in an Oocyte Donation Model: a Cluster Randomized Controlled Clinical Trial
NCT number | NCT03121924 |
Other study ID # | 2500 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | December 1, 2015 |
Est. completion date | August 1, 2019 |
Verified date | August 2019 |
Source | Hospital Italiano de Buenos Aires |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Analyze the effect of preincubation time of oocyte on the results of ICSI in a oocyte donation model.
Status | Completed |
Enrollment | 375 |
Est. completion date | August 1, 2019 |
Est. primary completion date | December 1, 2018 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | 18 Years to 32 Years |
Eligibility | Inclusion Criteria: - Oocytes retrieved from healthy donors, younger than 32 years old , with proven maternity(preference), who meet the admission criteria of ovodonation program: - The oocytes included will be the product of antagonist stimulation protocol and with Gnrh agonists trigger. (see annex) - Healthy women under 50 years of age , who meet the criteria as receptors into the ovodonation program. - Oocytes retrieved after 36.5 h + -1 h of administration of triptorelin acetate. - Only mature oocytes, in stage MII, will be included and injected. - Use of fresh or thawed semen for the ICSI. Exclusion Criteria: - Cases of severe male factor such as azoospermia or severe oligo-astheno-teratospermia( alone or combinated) - Sperm samples from surgical procedures (biopsy / testicular or epididymal puncture) - Donors with a polycystic ovarian profile, according to The Androgen Excess and PCOS Society (AES), 2006. - Thawed donated oocytes - Oocytes from patients who have previously donated within a period of less than three months. - Donors whith poor response (oocyte retrieved less than < 4 oocytes). - Suspicion or signs of Endometriosis in donor patient. |
Country | Name | City | State |
---|---|---|---|
Argentina | Hospital Italiano de Buenos Aires | Ciudad de buenos Aires | Buenos Aires |
Lead Sponsor | Collaborator |
---|---|
Hospital Italiano de Buenos Aires |
Argentina,
Harrison KL, Wilson LM, Breen TM, Pope AK, Cummins JM, Hennessey JF. Fertilization of human oocytes in relation to varying delay before insemination. Fertil Steril. 1988 Aug;50(2):294-7. — View Citation
Hassan HA. Cumulus cell contribution to cytoplasmic maturation and oocyte developmental competence in vitro. J Assist Reprod Genet. 2001 Oct;18(10):539-43. — View Citation
Ho JY, Chen MJ, Yi YC, Guu HF, Ho ES. The effect of preincubation period of oocytes on nuclear maturity, fertilization rate, embryo quality, and pregnancy outcome in IVF and ICSI. J Assist Reprod Genet. 2003 Sep;20(9):358-64. — View Citation
Jacobs M, Stolwijk AM, Wetzels AM. The effect of insemination/injection time on the results of IVF and ICSI. Hum Reprod. 2001 Aug;16(8):1708-13. — View Citation
Rienzi L, Ubaldi F, Anniballo R, Cerulo G, Greco E. Preincubation of human oocytes may improve fertilization and embryo quality after intracytoplasmic sperm injection. Hum Reprod. 1998 Apr;13(4):1014-9. — View Citation
Van de Velde H, De Vos A, Joris H, Nagy ZP, Van Steirteghem AC. Effect of timing of oocyte denudation and micro-injection on survival, fertilization and embryo quality after intracytoplasmic sperm injection. Hum Reprod. 1998 Nov;13(11):3160-4. — View Citation
Yanagida K, Yazawa H, Katayose H, Suzuki K, Hoshi K, Sato A. Influence of oocyte preincubation time on fertilization after intracytoplasmic sperm injection. Hum Reprod. 1998 Aug;13(8):2223-6. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Number of M2 oocytes at injection | Asessment of the number of M2 oocytes was made after the oocyte denudation and ICSI | four hours after oocyte retrieval | |
Primary | Number of normal fertilized oocytes after ICSI | Asessment of the normal fertilization rate was made 24 hours after the intervention. | 24 hours | |
Primary | Number of cleaving embryos | The embryo cleavage was evaluated after 48 hours and 72 hours after the ICSI was performed. | 72 hours | |
Primary | Number of TOP embryos | The embryos were morfologically classified into 4 categories . It considered TOP embryos those correctly fertilized at day 1, and with regular 6 to 8 cells at day 2 with less than 20% fragmentation and without multinuclear blastomeres. | 72 hours | |
Secondary | Implantation rate | The implantation rate was the ratio between the number of gestacional sacs and the number of transferred embryos. | 14 days after embryo trasfer | |
Secondary | Clinical pregnancy rate | Clinical pregnancy is confirmed by ultrasonography ,when one or more gestational sacs with heart activity are seen. | 6 to 7 week |
Status | Clinical Trial | Phase | |
---|---|---|---|
Withdrawn |
NCT02759705 -
Bladder Exstrophy (FIVES FertIlity Vesical Exstrophy Sexuality)
|
||
Not yet recruiting |
NCT02534857 -
A Study Comparing a Shorter Exposure of Oocyte to Spermatozoa Versus a Standard Incubation on the Live Birth Rate of In-vitro Fertilization Treatment
|
N/A | |
Enrolling by invitation |
NCT01803893 -
Prognostic Value of PIF Detection in Embryo Culture Media Correlation With Pregnancy Outcome
|
N/A | |
Completed |
NCT01888744 -
Preimplantation Genetic Diagnosis (PGD) With Gonadotropin-releasing Hormone (GnRH) Agonist Versus Antagonist
|
Phase 4 | |
Terminated |
NCT01173276 -
Intrauterine Insemination In HIV-Discordant Couples
|
N/A | |
Not yet recruiting |
NCT03680937 -
Methods for Fertility Preservation: Impact of Vitrification on in Vitro Matured Oocytes
|
||
Completed |
NCT03455062 -
Fertility Study of Women Who Received Organ Transplantation
|
N/A | |
Completed |
NCT02736214 -
Reproductive Life Plan-based Counseling With Men
|
N/A | |
Completed |
NCT01895192 -
Sperm Morphology by High Magnification in Fertility Men
|
N/A | |
Terminated |
NCT01614704 -
Impact of Sequential Chemotherapy on Young Patients Breast Cancer Treated Fertility
|
||
Terminated |
NCT01268592 -
Fertility Preservation in Female Cancer Patients
|
N/A | |
Terminated |
NCT01232972 -
Oocyte Cryopreservation
|
N/A | |
Completed |
NCT01012596 -
Creighton Model Effectiveness, Intentions and Behaviors Assessment (CEIBA)
|
||
Completed |
NCT00390754 -
Usefulness of Home Pregnancy Testing
|
N/A | |
Completed |
NCT00231504 -
Study of Follicle Stimulating Hormone (FSH) Receptor in Women With Low Antral Follicle Count
|
Phase 1 | |
Completed |
NCT03345264 -
The Find Your PATHS (Pragmatic Assessment of a Tool to Help Survivors) to Sexual Health and Parenthood Study
|
N/A | |
Recruiting |
NCT05414812 -
Intervening on Women's Health for Rural Young Breast Cancer Survivors
|
N/A | |
Active, not recruiting |
NCT02661932 -
Fertility Preservation in Breast Cancer Patients
|
Phase 4 | |
Recruiting |
NCT06172504 -
Ejaculation Frequency and Semen Parameters
|
||
Recruiting |
NCT02878434 -
Fertility Preservation in Young Women With Cancer
|